Primary structure of human neutrophil antigens 1a and 1b.


Journal

Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360

Informations de publication

Date de publication:
04 2020
Historique:
received: 20 09 2019
revised: 16 12 2019
accepted: 20 01 2020
pubmed: 20 2 2020
medline: 9 9 2020
entrez: 20 2 2020
Statut: ppublish

Résumé

Neutrophil specific Fcγ receptor IIIb (CD16b) is a low-affinity IgG receptor. Its polymorphic variants are associated with human neutrophil antigens (HNA). HNA-1a and HNA-1b differ in four amino acids. Immunization can lead to the production of alloantibodies. The exact contribution of four amino acid exchanges for the formation of HNA-1a, -1b epitopes is currently unknown. Permutation of each polymorphic amino acid from wild-type CD16b cDNA constructs was performed and expressed on HEK293 cells. All 16 receptor variants were produced and tested against 19 well-characterized HNA antisera in an antigen capture assay. Analyzing the reaction pattern revealed that anti-HNA-1a antibodies can bind whenever asparagine (N) is present in position 65, regardless of the three other positions (CD16b *N**). Anti-HNA-1b antibodies can bind when serine (S) is present in position 36 (CD16b S***), when N is present in position 82 (CD16b **N*), or both (CD16b S*N*). CD16b variants with N65 and S36 and/or N82 (such as CD16b SNN*) bind both, anti-HNA-1a and anti-HNA-1b alloantibodies. If these specific amino acids are missing (as in CD16b RSD*), no antibodies will bind. Whereas the primary structure of HNA-1a and HNA-1b usually differs in four amino acids, epitope composition is not "antithetical". N65 alone determines the presence of HNA-1a, and S36 and/or N82 determine the presence of HNA-1b. Amino acid 106 does not participate in epitope formation. Our findings are of specific relevance when a HNA-1 phenotype is predicted from a genotype.

Sections du résumé

BACKGROUND
Neutrophil specific Fcγ receptor IIIb (CD16b) is a low-affinity IgG receptor. Its polymorphic variants are associated with human neutrophil antigens (HNA). HNA-1a and HNA-1b differ in four amino acids. Immunization can lead to the production of alloantibodies. The exact contribution of four amino acid exchanges for the formation of HNA-1a, -1b epitopes is currently unknown.
STUDY DESIGN AND METHODS
Permutation of each polymorphic amino acid from wild-type CD16b cDNA constructs was performed and expressed on HEK293 cells. All 16 receptor variants were produced and tested against 19 well-characterized HNA antisera in an antigen capture assay.
RESULTS
Analyzing the reaction pattern revealed that anti-HNA-1a antibodies can bind whenever asparagine (N) is present in position 65, regardless of the three other positions (CD16b *N**). Anti-HNA-1b antibodies can bind when serine (S) is present in position 36 (CD16b S***), when N is present in position 82 (CD16b **N*), or both (CD16b S*N*). CD16b variants with N65 and S36 and/or N82 (such as CD16b SNN*) bind both, anti-HNA-1a and anti-HNA-1b alloantibodies. If these specific amino acids are missing (as in CD16b RSD*), no antibodies will bind.
CONCLUSION
Whereas the primary structure of HNA-1a and HNA-1b usually differs in four amino acids, epitope composition is not "antithetical". N65 alone determines the presence of HNA-1a, and S36 and/or N82 determine the presence of HNA-1b. Amino acid 106 does not participate in epitope formation. Our findings are of specific relevance when a HNA-1 phenotype is predicted from a genotype.

Identifiants

pubmed: 32072650
doi: 10.1111/trf.15707
doi:

Substances chimiques

Antigen-Antibody Complex 0
DNA, Complementary 0
FCGR3B protein, human 0
GPI-Linked Proteins 0
Isoantibodies 0
Isoantigens 0
Receptors, IgG 0
neutrophil-specific antigen NA1, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

815-821

Informations de copyright

© 2020 The Authors. Transfusion published by Wiley Periodicals, Inc. on behalf of AABB.

Références

Frank MM, Hamburger MI, Lawley TJ, et al. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 1979;300:518-23.
Gresham HD, Clement LT, Lehmeyer JE, et al. Stimulation of human neutrophil Fc receptor-mediated phagocytosis by a low molecular weight cytokine. J Immunol 1986;137:868-75.
Kipps TJ, Parham P, Punt J, et al. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med 1985;161:1-17.
Huizinga TW, Kleijer M, Tetteroo PA, et al. Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16). Blood 1990;75:213-7.
Flesch BK, Curtis BR, de Haas M, et al. Update on the nomenclature of human neutrophil antigens and alleles. Transfusion 2016;56:1477-9.
Qiu WQ, de Bruin D, Brownstein BH, et al. Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination. Science 1990;248:732-5.
Ory PA, Goldstein IM, Kwoh EE, et al. Characterization of polymorphic forms of Fc receptor III on human neutrophils. J Clin Invest 1989;83:1676-81.
Bux J, Stein EL, Bierling P, et al. Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb. Blood 1997;89:1027-34.
Werth S, Bayat B, Tjahjono Y, et al. Rapid enzyme-linked immunosorbent assay for the detection of antibodies against human neutrophil antigens -1a, −1b, and -1c. Transfusion 2013;53:193-201.
Simtong P, Romphruk AV, Traum A, et al. Molecular and Functional Characterization of Fcγ Receptor IIIb-Ligand Interaction: Implications for Neutrophil-Mediated Immune Mechanisms in Malaria. Infect Immun 2018;86:e00924-17.
Lucas G, Porcelijn L, Fung YL, et al. External quality assessment of human neutrophil antigen (HNA)-specific antibody detection and HNA genotyping from 2000 to 2012. Vox Sang 2013;105:259-69.
Matsuo K, Procter J, Stroncek D. Variations in genes encoding neutrophil antigens NA1 and NA2. Transfusion 2000;40:645-53.
Flesch BK, Doose S, Siebert R, et al. FCGR3 variants and expression of human neutrophil antigen-1a, −1b, and -1c in the populations of northern Germany and Uganda. Transfusion 2002;42:469-75.
Tong Y, Jin J, Yan L, et al. FCGR3B gene frequencies and FCGR3 variants in a Chinese population from Zhejiang province. Ann Hematol 2003;82:574-8.
Covas DT, Kashima S, Guerreiro JF, et al. Variation in the FcgammaR3B gene among distinct Brazilian populations. Tissue Antigens 2005;65:178-82.
Xu G, He Q, Shou Z, et al. NA1/NA2 heterozygote of FCGR3B is a risk factor for progression of IgA nephropathy in Chinese. J Clin Lab Anal 2007;21:298-302.
Blum KS, Tong Y, Siebert R, et al. Evidence for gene recombination in FCGR3 gene variants. Vox Sang 2009;97:69-76.
Terzian CC, Chiba AK, Santos VC, et al. FCGR3B*03 allele inheritance pattern in Brazilian families and some new variants of gene FCGR3B. Transfusion 2012;52:629-34.
Bux J, Kober B, Kiefel V, et al. Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal-antibody-specific immobilization of granulocyte antigens. Transfus Med 1993;3:157-62.
Reil A, Sachs UJ, Siahanidou T, et al. HNA-1d: a new human neutrophil antigen located on Fcg receptor IIIb associated with neonatal immune neutropenia. Transfusion 2013;53:2145-51.
van den Tooren-de Groot R, Ottink M, Huiskes E, et al. Management and outcome of 35 cases with foetal/neonatal alloimmune neutropenia. Acta Paediatr 2014;103:e467-74.
Stroncek D. Neutrophil alloantigens. Transfus Med Rev 2002;16:67-75.
Trounstine ML, Peltz GA, Yssel H, et al. Reactivity of cloned, expressed human Fc gamma RIII isoforms with monoclonal antibodies which distinguish cell-type-specific and allelic forms of Fc gamma RIII. Int Immunol 1990;2:303-10.
Grabowski C, Jorks S, Kroll H. Genotyping of human neutrophil antigens 1, 3, 4 and 5 using a novel multiplex polymerase chain reaction. Transfus Med 2019;29:110-5.

Auteurs

Ulrich J Sachs (UJ)

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.

Clemens Radke (C)

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.

Gregor Bein (G)

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.

Claudia Grabowski (C)

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.

Piyapong Simtong (P)

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.
Centre for Research and Development, Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.

Jürgen Bux (J)

Ruhr University, Bochum, Germany.

Behnaz Bayat (B)

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.

Angelika Reil (A)

German Red Cross Blood Service West, Hagen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH